• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Research and Development Forecast of China Contrast Media (Contrast Agent) Market, 2014 - Product Image

Research and Development Forecast of China Contrast Media (Contrast Agent) Market, 2014

  • Published: January 2014
  • Region: China
  • 42 Pages
  • Huidian Research

With the mushroom growth of world diagnostic imaging equipments and apparatuses, as for X-CT contrast media, iodinated contrast media serving as the main one is witnessing unprecedented development. Iohexol is featured with great security, high contrast ratio, lower osmotic pressure and small toxicity for human bodies etc. has become the best-selling contrast media in international market. The sales amount of all kinds of contrast media across the world has exceeded USD 23 billion in 2013, with growth continued to rise at the rate of 6% to 8%.

In recent two years, as for the drug procurement in 22 cities in China, there were six major varieties of contrast media, namely, iohexol, iopromide, gadopentetate dimeglumine, iopamidol, ioversol and meglumine diatrizoate, of which the former three varieties were listed among the best-selling 200 drugs. Recently, hospitals attached more importance to instrument testing, boosting the development of contrast media market.

According to the procurement of contrast media from sampled hospitals in 16 cities, iohexol and iopromide rank first and second respectively, accounting for 43% and 32% of market shares of CT contrast media respectively READ MORE >

1. Development Overview of Contrast Media Industry
1.1 Overview of Industry
1.1.1Product Concept
1.1.2 Product Classification
1.2 Industry China

2. Development Overview of Global Contrast Media Industry
2.1 Development Status
2.2 Application for International Contrast Media Patents

3. Environment Analysis of China's Contrast Media Industry
3.1 China's Economic Development Environment
3.2 Policy Environment
3.2.1 National Basic Medical Insurance, Employment Injury Insurance and Maternity Insurance Drug Catalogue
3.2.2 Suggestions on Consolidating Essential Medicine System and New Operation Mechanism of Grass Roots
3.3 Domestic Technological Level of Contrast Media
3.3.1 Technical Status
3.3.2 Patent Application in China

4. Analysis on China's Contrast Media Industry
4.1 Domestic Market Status and Forecast
4.2 Segment Products
4.2.1 Much Attention on Iodized Salt Type of Products
4.2.2 Ultravist Dominates Iopromide Market
4.2.3 Imported and Domestic Iohexol Have Equal Shares
4.2.4 Iopamidol vs. Ioversol
4.2.5 Differences between Domestic and Overseas Gadopentetate Dimeglumine
4.3 Factors Affecting Contrast Media Development
4.3.1 Improvement of Social Economy
4.3.2 Wide Application of Imaging Diagnostic and Treatment Equipment
4.3.3 Improvement of Imaging Diagnostic and Treatment Method
4.3.4 Changes of Seeing a Doctor

5. Competitive Landscape of China's Contrast Media Industry
5.1 Competitiveness Analysis
5.1.1 Upstream Bargaining Power
5.1.2 Periodic Fluctuation of Consumers' Bargaining Power
5.1.3 Potential Entrant
5.1.4 Competition in the Industry
5.2 Concentration Ratio of Contrast Media Industry
5.2.1 Concentration Ratio of China's CT Contrast Media Market
5.2.2 Concentration Ratio of China's MRI (Magnetic Resonance Imaging) Contrast Media Market

6. Import and Export Data of Contrast Media Products
6.1 Import and Export Data of X-Ray Contrast Media and Diagnostic Reagent, 2010-2013
6.2 Import Sources and Export Destinations of X-Ray Contrast Media and Diagnostic Reagent, 2013

7. Domestic Major Contrast Media Manufacturing Enterprises
7.1 Yangtze River Pharmaceutical Group
7.1.1 Company Profile
7.1.2 Main Business
7.1.3 Competitive Edge
7.1.4 Business Performance
7.1.5 Future Development Strategy
7.2 BEILU Pharmaceutical Co., Ltd.
7.2.1 Company Profile
7.2.2 Main Business
7.2.3 Competitive Edge
7.2.4 Business Performance
7.2.5 Future Development Strategy
7.3 Jiangsu Hengrui Medicine Co., Ltd.
7.3.1 Company Profile
7.3.2 Main Business
7.3.3 Competitive Edge
7.3.4 Business Performance
7.3.5 Future Development Strategy
7.4 China Resources Double-crane Pharmaceutical Co., Ltd.
7.4.1 Company Profile
7.4.2 Main Business
7.4.3 Competitive Edge
7.4.4 Business Performance
7.4.5 Market Structure of Cardiac Ultrasound Contrast Media
7.5 Shanghai Xudong Haipu Pharmaceutical Co., Ltd.
7.5.1 Company Profile
7.5.2 Main Business
7.5.3 Product Performance

8. Investment and Development Trend of Contrast Media Industry
8.1 Investment Opportunities
8.1.1 Rising Health Consciousness
8.1.2 Increasing Number of Medical Treatment Equipment (MRI Equipment)
8.2 Investment Risks
8.3 Development Trend of China's Contrast Media Industry
8.3.1 X-Ray CT Contrast Media
8.3.2 MRI Contrast Media
8.3.3 Ultrasound Contrast Media
8.4 Suggestions
8.4.1 Large-Scale and Specialized Enterprise Development
8.4.2 Strengthen Technology R&D
8.4.3 Scientific Enterprise Management
8.4.4 Build Brand Awareness

- Yangtze River Pharmaceutical Group
- BEILU Pharmaceutical Co., Ltd.
- Jiangsu Hengrui Medicine Co., Ltd.
- China Resources Double-crane Pharmaceutical Co., Ltd.
- Shanghai Xudong Haipu Pharmaceutical Co., Ltd.

Note: Product cover images may vary from those shown

ALSO AVAILABLE IN THE FOLLOWING LANGUAGES

RELATED PRODUCTS

Our Clients

Our clients' logos